{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:24:36Z","timestamp":1789208676636,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ijpharm.2008.04.034","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T15:50:25Z","timestamp":1209570625000},"page":"148-155","source":"Crossref","is-referenced-by-count":74,"title":["Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs"],"prefix":"10.1016","volume":"360","author":[{"given":"Lina","family":"Fossati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dechaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Hardillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Chevillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bolze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Maubon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2008.04.034_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.2600810908","article-title":"Epithelial transport of drugs in cell culture. VII. Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells","volume":"81","author":"Anderberg","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib2","first-page":"305","article-title":"Cell cultures as models for drug absorption across the intestinal mucosa","volume":"8","author":"Artursson","year":"1991","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1023\/A:1012155124489","article-title":"Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond","volume":"14","author":"Artursson","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1015800312910","article-title":"The use of cultured epithelial and endothelial cells for drug transport and metabolism studies","volume":"7","author":"Audus","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1023\/A:1026402410783","article-title":"The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds","volume":"17","author":"Aungst","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1023\/A:1018882221008","article-title":"Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption","volume":"16","author":"Balon","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib8","series-title":"Klinisch-pharmakologische Datensammlung","author":"Bircher","year":"1999"},{"key":"10.1016\/j.ijpharm.2008.04.034_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/00498250310001614286","article-title":"Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells","volume":"33","author":"Borlak","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ijpharm.2008.04.034_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1023\/A:1011022931368","article-title":"Profound effect of plasma protein binding on the polarized transport of furosemide and verapamil in the Caco-2 model","volume":"18","author":"Chung","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v14.i3.20","article-title":"A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model","volume":"14","author":"Delie","year":"1997","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib12","series-title":"Human Tumor Cells In Vitro","first-page":"115","author":"Fogh","year":"1975"},{"key":"10.1016\/j.ijpharm.2008.04.034_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","article-title":"One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice","volume":"59","author":"Fogh","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib14","first-page":"344","article-title":"CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells","volume":"24","author":"Gan","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib15","doi-asserted-by":"crossref","first-page":"C260","DOI":"10.1152\/ajpcell.1984.247.3.C260","article-title":"Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters","volume":"247","author":"Grasset","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1568026013395010","article-title":"Assessing the absorption of new pharmaceuticals","volume":"1","author":"Hidalgo","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijpharm.2008.04.034_bib18","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1023\/A:1018986605929","article-title":"Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase","volume":"16","author":"Hu","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jps.10408","article-title":"Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2","volume":"92","author":"Ingels","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1476-5381.1993.tb13914.x","article-title":"Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein","volume":"110","author":"Karlsson","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(01)00698-6","article-title":"Permeability of lipophilic compounds in drug discovery using in vitro human absorption model, Caco-2","volume":"222","author":"Krishna","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijpharm.2008.04.034_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/clpt.1983.233","article-title":"Imipramine serum protein binding in healthy subjects","volume":"34","author":"Kristensen","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0090-9556(24)02976-3","article-title":"Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability","volume":"32","author":"Lau","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-197702010-00001","article-title":"Clinical pharmacokinetics of digoxin","volume":"2","author":"Lisalo","year":"1977","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/jm049711o","article-title":"Exploring the role of different drug transport routes in permeability screening","volume":"48","author":"Matsson","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1472-8206.2007.00550.x","article-title":"Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR","volume":"21","author":"Maubon","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar molecular surface properties predict the intestinal absorption of drugs in humans","volume":"14","author":"Palm","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/03639040500465991","article-title":"Use of simulated intestinal fluids with Caco-2 cells and rat ileum","volume":"32","author":"Patel","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib33","first-page":"323","article-title":"Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture","volume":"47","author":"Pinto","year":"1983","journal-title":"Biol. Cell"},{"key":"10.1016\/j.ijpharm.2008.04.034_bib34","first-page":"634","article-title":"Comparative studies of drug-metabolizing enzymes in dog, monkey and human small intestines and in Caco-2 cells","volume":"24","author":"Prueksaritanont","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib35","first-page":"151","article-title":"Transmembranous transport of drugs: implications for kinetics and drug action","volume":"35","author":"Stratmann","year":"1997","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(02)00347-2","article-title":"Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs","volume":"246","author":"Takahashi","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1211\/0022357991773366","article-title":"The influence of plasma binding on absorption\/exsorption in the Caco-2 model of human intestinal absorption","volume":"51","author":"Walgren","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/ci980029a","article-title":"Prediction of human intestinal absorption of drug compounds from molecular structure","volume":"38","author":"Wessel","year":"1998","journal-title":"J. Chem. Inform. Comput. Sci."},{"key":"10.1016\/j.ijpharm.2008.04.034_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517308003190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517308003190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:44:36Z","timestamp":1738194276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517308003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0378517308003190"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2008.04.034","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}